Protein pool maintenance during oxidative stress

Current Pharmaceutical Design

Volumn 15, Issue 26, 2009, Pages 3043-3051

  Catalgol, B ^a,b   Grune, T ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Oxidative stress; Proteasome; Protein oxidation; Proteolysis; Reactive species

Indexed keywords

4 HYDROXYNONENAL; BORTEZOMIB; CALPAIN; CASPASE; HEXANAL; LACTACYSTIN; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEASOME; UBIQUITIN PROTEIN LIGASE;

CELL FUNCTION; CELL LYSATE; DNA DAMAGE; DRUG ACTIVITY; HUMAN; HYDROPHOBICITY; LIPID PEROXIDATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN OXIDATION; REVIEW; UPREGULATION;

ANTIOXIDANTS; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 70449458038     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789058129     Document Type: Review

References (113)

1. Halliwell B, Gutteridge JMC. In: Halliwell B, Gutteridge JMC Ed, Free Radicals in Biology and Medicine. New York: Oxford University Press 2007; pp. 268-340.
2. Griffiths HR, Møller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, et al. Biomarkers. Mol Aspects Med 2002; 23: 101-208.
3. Grune T, Reinheckel T, Davies KJA. Degradation of oxidized proteins in mammalian cells. FASEB J 1997; 11: 526-534 (Pubitemid 27274426)
4. Grune T. Oxidative stress, aging and the proteasomal system. Biogerontology 2000; 1: 31-40.
5. Davies MJ. Singlet-oxygen mediated damage to proteins and its consequences. Biochem Biophys Res Commun 2003; 305: 761-770
6. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790-796 (Pubitemid 34439249)
7. Grune T, Klotz LO, Gieche J, Rudeck M, Sies H. Protein oxidation and proteolysis by the nonradical oxidants singlet oxygen or peroxynitrite. Free Radic Biol Med 2001; 30: 1243-1253 (Pubitemid 32463935)
8. Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci 2000; 899: 191-208.
9. Dean RT, Shanlin FU, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324: 1-18. (Pubitemid 27229359)
10. Davies KJA. Protein damage and degradation by oxygen radicals I. General aspects. J Biol Chem 1987; 262: 9895-9901
11. Davies KJA, Delsignore ME, Lin SW. Protein damage and degradation by oxygen radicals II. Modification of amino acids. J Biol Chem 1987; 262: 9902-9907
12. Davies KJA, Delsignore ME. Protein damage and degradation by oxygen radicals III. Modification of secondary and tertiary structure. J Biol Chem 1987; 262: 9908-9913
13. Davies KJA, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals IV. Degradation of denatured protein. J Biol Chem 1987; 262: 9914-9920
14. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 1993; 62: 797-821. (Pubitemid 23237888)
15. Giulivi C, Davies KJA. Dityrosine and tyrosine oxidation products are endogenous markers for selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19S) proteasome. J Biol Chem 1993; 268: 8752-8759 (Pubitemid 23118663)
16. Shringarpure R, Davies KJA. Protein turnover by the proteasome in aging and disease. Free Radic Biol Med 2002; 32: 1084-1089 (Pubitemid 34603346)
17. Grune T, Jung T, Merker K, Davies KJA. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004; 36: 2519-2530 (Pubitemid 39119763)
18. Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 1996; 21: 871-888 (Pubitemid 26365282)
19. Yin D. Lipofuscin-like fluorophores can result from reactions between oxidized ascorbic acid and glutamine. Carbonylprotein cross-linking may represent a common reaction in oxygen radical and glycosylation-related ageing processes. Mech Aging Dev 1992; 62: 35-46.
20. Chao C, Ma Y, Stadtman ER. Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc Natl Acad Sci USA 1997; 94: 2969-2974 (Pubitemid 27157248)
21. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233: 346-357 (Pubitemid 24177560)
22. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997; 23: 361-366
23. Alamdari DH, Kostidou E, Paletas K, Sarigianni M, Konstas AG, Karapiperidou A, et al. High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. Free Radic Biol Med 2005; 39: 1362-1367
24. Uchida K, Stadtman ER. Quantitation of 4-hydroxynonenal protein adducts. Methods Enzymol 1994; 233: 371-380
25. Puig A, Gilbert HF. Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. J Biol Chem 1994; 269: 7764-7771 (Pubitemid 24217992)
26. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963-13966
27. Levine RL, Mosoni L, Berlett BS, Stadtman ER. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 1996; 93: 15036-15040
28. Levine RL, Berlett BS, Moskovitz J, Mosoni L, Stadtman ER. Methionine residues may protect proteins from critical oxidative damage. Mech Ageing Dev 1999; 107: 323-332
29. Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med 1995; 18: 93-105.
30. Noonan EJ, Place RF, Giardina C, Hightower LE. HSP70B regulation and function. Cell Stress Chaperones 2007; 12: 393-402.
31. Bader N, Grune T. Protein oxidation and proteolysis. Biol Chem 2006; 387: 1351-1355
32. Mehlhase J, Grune T. Proteolytic response to oxidative stress in mammalian cells. Biol Chem 2002; 383: 559-567
33. Bohley P, Seglen PO. Proteases and proteolysis in the lysosome. Experentia 1992; 48: 151-157
34. Mellgren RL. Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB J 1987; 1: 110-115
35. Roberg K, Ollinger K. Oxidative stress cause relocation of lysosomal enzymes cathepsin D with ensuing apoptosis in neuronal rat cardiomyocytes. Am J Pathol 1998; 152: 1151-1156
36. Jessup W, Mander EL, Dean RT. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochem Biophys Acta 1992; 1126: 167-177
37. Grant AJ, Jessup W, Dean RT. Inefficient degradation of oxidized regions of protein molecules. Free Radic Res Commun 1993; 18: 259-267
38. Terman A, Brunk UT. Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev 1998; 104: 277-291
39. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 2000; 14: 1490-1498
40. Hofmann K, Falquet L. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation system. Trends Biochem Sci 2001; 26: 347-350
41. Dean RT, Thomas SM, Garner A. Free radical mediated fragmentation of monoamine oxidase in the mitochondrial membrane. Biochem J 1986; 240: 489-494
42. Grant AJ, Jessup W, Dean RT. Enhanced enzymatic degradation of radical damaged mitochondrial membrane components. Free Radical Res Commun 1993; 19: 125-134
43. Mortensen AM, Novack RF. Enhanced proteolysis and changes in membrane-associated calpain following phenylhydrazine insult to human red cells. Toxicol Appl Pharmacol 1991; 110: 435-449
44. Beppu M, Inoue M, Ishikawa T, Kikugawa K. Presence of membrane- bound proteinases that preferentially degrade oxidatively damaged erythrocyte membrane proteins as secondary antioxidant defense. Biochim Biophys Acta 1994; 1196: 81-87
45. Young J, Kane LP, Exley M, Wileman T. Regulation of selective protein degradation in the endoplasmic reticulum by redox potential. J Biol Chem 1993; 268: 19810-19818
46. Ray SK, Wilford GG, Crosby CV, Hogan EL, Banik NL. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res 1999; 829: 18-27.
47. Miyoshi H, Umeshita K, Sakon M, Imajoh-Ohmi S, Fujitani K, Gotoh M, et al. Calpain activation in plasma membrane bleb formation during tert-butyl-hydroperoxide-induced rat hepatocyte injury. Gastroenterology 1996; 110: 1897-1904
48. McCracken E, Dewar D, Hunter AJ. White matter damage following systemic injection oft he mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res 2001; 892: 329-335
49. Davies KJA. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995: 61: 1-31.
50. Dice JF, Goldberg AL. Relationship between in vivo degradative rates and isoelectric points of proteins. Proc Natl Acad Sci USA 1975; 72: 3893-3897
51. Bota DA, Davies KJA. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002; 4: 674-680
52. Bota DA, Remmen HV, Davies KJA. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 2002; 532: 103-106
53. Chan SL, Mattson MP. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58: 167-190
54. Sleiman RJ, Stewart BW. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitochondrial cell death. Clin Cancer Res 2000; 6: 3756-3765
55. Grune T, Merker K, Sandig G, Davies KJA. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 2003; 305: 709-718
56. Grune T, Reinheckel T, Davies KJA. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem 1996; 271: 15504-15509
57. Grune T, Reinheckel T, Joshi M, Davies KJA. Proteolysis in cultured liver epithelial cells during oxidative stress. J Biol Chem 1995; 270: 2344-2351
58. Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJA. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem 1998; 273: 10857-10862
59. Sitte N, Merker K, Grune T. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS Lett 1998; 440: 399-402.
60. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994; 79: 13-21.
61. Coux O, Tanaka K, Goldberg A. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65: 801-807
62. Rivett AJ. Proteasomes: multicatalytic proteinase complexes. Biochem J 1993; 291: 1-10.
63. Rivett AJ. Intracellular distribution of proteasomes. Curr Opin Immunol 1998; 10: 110-114
64. Glickman MH, Ciechanover A. The ubiquitin proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373-428.
65. Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jensch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999; 96: 635-644
66. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68: 1015-1068 (Pubitemid 29449214)
67. Wilkinson KD. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol 2000; 11: 141-148
68. Hoffmann L, Rechsteiner M. Activation of the multicatalytic protease. J Biol Chem 1994; 269: 16890-16895
69. Ustrell V, Realini C, Pratt G, Rechneister M. Human lymphoblast and erythrocyte multicatalytic proteases: differential peptidase activities and responses to the 11S regulator. FEBS Lett 1995; 376: 155-158
70. Kania MA, DeMartino GN, Baumeister W, Goldberg AL. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator. Eur J Biochem 1996; 236: 510-516
71. Pacifici RE, Salo DC, Davies KJA. Maxroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med 1989; 7: 521-536
72. Pacifici RE, Kono Y, Davies KJA. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 1993; 268: 15405-15411
73. Guilivi C, Pacifici RE, Davies KJA. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arc Biochem Biophys 1994; 311: 329-341
74. Davies KJA. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001; 83: 301-310
75. Friguet B, Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett 1997; 405: 21-25
76. Shringarpure R, Grune T, Davies KJA. Protein oxidation and 20S proteasome dependent proteolysis in mammalian cells. Cell Mol Life Sci 2001; 58: 1442-1450 (Pubitemid 32964414)
77. Shringarpure R, Grune T, Mehlhase J, Davies KJA. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278: 311-318
78. Li N, Lerea KM, Etlinger JD. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Biochem Biophys Res Commun 1996; 225: 855-860
79. Mason GG, Hendil KB, Rivett AJ. Phosphorylation of proteasomes in mammalian cells. Eur J Biochem 1996; 238: 453-462
80. Merker K, Ullrich O, Schmidt H, Sitte N, Grune T. Stability of the nuclear protein turnover during cellular senescence of human fibroblasts. FASEB J 2003; 17: 1963-1965
81. Arnold J, Grune T. PARP-mediated proteasome activation: a coordination of DNA repair and protein degradation? Bioessays 2002; 24: 1060-1065
82. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJA. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci USA 1999; 96: 6223-6228
83. Mayer-Kuckuk P, Ullrich O, Ziegler M, Grune T, Schweiger M. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro. Biochem Biophys Res Commun 1999; 259: 576-581
84. Ullrich O, Grune T. Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Free Radic Biol Med 2001; 31: 887-893
85. Catalgol B, Grune T. Turnover of oxidatively modified proteins: the usage of in vitro and metabolic labeling. Free Rad Biol Med 2009; 46: 8-13.
86. Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJA. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 1990; 265: 11919-11927 (Pubitemid 120013349)
87. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001; 8: 739-758
88. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. The proteasome. Annu Rev Biophys Biomol Struct 1999; 28: 295-317.
89. Vinitsky A, Michaud C, Powers JC, Orlowski M. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 1992; 31: 9421-9428
90. Bogyo M, McMaster JS, Gaczynska M, Tortorella D, Goldberg AL, Ploegh H. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci USA 1997; 94: 6629-6634
91. Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR, Grenier L, et al. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett 1998; 8: 333-338
92. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995; 268: 726-731
93. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J Biol Chem 1996; 271: 7273-7276
94. Groll M, Kim KB, Kairies N, Huber R, Crews CM. Crystal structure of epoxomicin: 20s proteasome reveals a molecular basis for selectivity of α',β'-epoxyketone proteasome inhibitors. J Am Chem Soc 2000; 122: 1237-1238
95. Wu WK, Wu YC, Yu L, Li ZJ, Sung JJ, Cho CH. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Biophys Res Commun 2008; 374: 258-263
96. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999; 59: 2615-2622
97. Stenner F, Liewen H, Zweifel M, Weber A, Tchinda J, Bode B, et al. Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo. Cancer Sci 2008; 99: 1847-1852
98. Teicher BA, Ara G, Herbst R, Palombella VJ, Adams J. The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res 1999; 5: 2638-2645
99. Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 2001; 61: 3071-3076
100. Adams J, Elliott PJ. New agents in cancer clinical trials. Oncogene 2000; 19: 6687-6692
101. Hamel FG, Bennett RG, Harmon KS, Duckworth WC. Insulin inhibition of proteasome activity in intact cells. Biochem Biophys Res Commun 1997; 234: 671-674
102. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJA, Grune T. Comparative resistance oft he 20S and 26S proteasome to oxidative stress. Biochem J 1998; 335: 637-642
103. Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 2000; 377: 65-68
104. Shang F, Gong X, Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. J Biol Chem 1997; 272: 23086-23093
105. Jahngen-Hodge J, Obin MS, Gong X, Shang F, Nowell TR Jr, Gong J, et al. Regulation of ubiquitin conjugating enzymes by glutathione following oxidative stress. J Biol Chem 1997; 272: 28218-28226
106. Strack PR, Waxman L, Fagan JM. Activation of the multicatalytic endopeptidase by oxidants. Effects on enzyme structure. Biochemistry 1996; 35: 7142-7149
107. Davies JM, Horwitz DA, Davies KJA. Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med 1993; 15: 637-643
108. Bulteau AL, Szweda LI, Friguet B. Age dependent declines in proteasome activity in the heart. Arch Biochem Biophys 2002; 397: 298-304.
109. Widmer R, Ziaja I, Grune T. Protein oxidation and degradation during aging: role in skin aging and neurodegeneration. Free Radic Res 2006; 40: 1259-1268
110. Friguet B. Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett 2006; 580: 2910-2916
111. Corcoran BM, Stanton C, Fitzgerald G, Ross RP. Life under stress: the probiotic stress response and how it may be manipulated. Curr Pharm Des 2008; 14(14): 1382-1399
112. Dalla Libera L, Vescovo G, Volterrani M. Physiological basis for contractile dysfunction in heart failure. Curr Pharm Des 2008; 14(25): 2572-2581
113. Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 2008; 14(10): 953-961